Red SEC after dark One by one We going to expose

New Post Public Reply Private Reply Replies (0) Message Board
redspeed
664
Red SEC after dark

One by one

We going to expose them all

The fearless

Lets start with the bearded old man

jobynimble

"That’s the problem, too many snapping lately because of not paying attention to what should be and shouldn’t be done..."

Maybe you should pay attention joby?

problemo with the tick tock eh?

"Please stop with the off topic bs, there are plenty of other boards in Ihub to discuss politics..."

"You are getting stressout joby snapper"

"How many times do people need to be warned about off topic posts?"

"Why aren’t the mods deleting these off topic posts?"

"My rant is done..."

I don't think your rant is done...tick toc

OMG, this on your fake "DD Support Board and Research Team"

"I get blood tested every six months because of my heart condition and I’ll take Vitamin D if I’m low but that rarely happens, I do take C and D..."

High blood pressure and stress of screwing people over might take a toll on the ticker, eh joby?

Tick Toc...

What you reap, you sow

I wish your heart another another few months

Sucks the stress of bashing on a MB has taking a toll on the ole ticker

Maybe stepping down as a mod would give you a few months more and a chance for your Vitamin D to catch up, eh?

BTW, most people in the northern half of the US are low on Vitamin D

So stop crying out loud

Yup, I am going to do a deep dive into why you hate VERB so much

I will start with the mods and will help the rest that have 'heart burn" over a high risk, high reward stock.

No crying in baseball

No crying to the DD Support Board and Research Team





TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading